Pertuzumab and its accelerated approval: Evolving treatment paradigms and new challenges in the management of HER2-positive breast cancer
- Ciara C. O'Sullivan
- , Roisin M. Connolly
- Johns Hopkins University
- National Institutes of Health
Research output: Contribution to journal › Article › peer-review